AOD-9604
Reported Onset
2–4 weeks
Primary Use
Targeted fat metabolism and body composition improvement without GH-related side effects.
Dose
300mcg - 500mcg
Frequency
Daily (fasted)
Tesamorelin
Reported Onset
2–4 weeks
Primary Use
Visceral fat reduction and GH stimulation.
Dose
1mg - 2mg
Frequency
Daily
Community Verdict
Both target fat loss; AOD via lipolysis, Tesamorelin via GH axis. The community generally selects between AOD-9604 and Tesamorelin based on their specific goals and experience. Both compounds are available through physician-supervised protocols at Alukard, where a physician can help determine which is most appropriate for your situation.
Get a Physician-Supervised Protocol for AOD-9604 or Tesamorelin at Alukard
Community experiences are a starting point — but a physician-supervised protocol from Alukard gives you pharmaceutical-grade compounds, proper dosing, lab monitoring, and the safety of medical oversight.
MD
Supervised
GMP
Certified
Labs
Monitoring
COA
Verified